ArticleACS medicinal chemistry letters2021

Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor.

Malcolm P Huestis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.